Role Definition
| Field | Value |
|---|---|
| Job Title | Immunologist (Research Immunologist) |
| Seniority Level | Mid-Level (5-10 years post-PhD, independent research capability) |
| Primary Function | Studies immune system function, develops immunotherapies, and researches autoimmune diseases, vaccines, and immune-related disorders. Designs and executes experiments using techniques such as flow cytometry, ELISA, cell culture, animal models, and single-cell sequencing. Analyses complex immunological datasets, writes grants, publishes findings, mentors junior researchers, and collaborates across disciplines in academia, pharmaceutical/biotech, or government research institutions. |
| What This Role Is NOT | Not a clinical allergist treating patients in an outpatient setting (clinical practice, different risk profile). Not a lab technician running routine assays under supervision (lower autonomy, would score Yellow). Not a medical scientist with broader clinical trial focus (SOC 19-1042, scored 54.5 Green). Not an epidemiologist (population-level disease surveillance). Not a postdoctoral fellow (supervised, less independence -- would score lower). |
| Typical Experience | PhD in immunology, microbiology, or related biomedical science (5-7 years). 2-5 years postdoctoral training. Some hold MD/PhD. Total 10-15 years post-bachelor's before independent mid-level research practice. |
Seniority note: Junior (postdoctoral fellow, 0-3 years post-PhD) would score lower Yellow -- more routine protocol execution, less grant strategy, weaker publication independence. Senior PIs and department heads with established immunology programmes would score higher Green (~58-63) due to leadership accountability, institutional responsibility, and strategic direction-setting.
- Protective Principles + AI Growth Correlation
| Principle | Score (0-3) | Rationale |
|---|---|---|
| Embodied Physicality | 1 | Wet lab work -- flow cytometry panel setup and optimization, cell culture, animal immunology models, tissue processing, ELISA, and Western blot. All within structured, BSL-2/BSL-3 laboratory environments. Lab robotics handle some high-throughput screening but complex immune assay troubleshooting and animal work remain hands-on. |
| Deep Interpersonal Connection | 1 | Mentors postdocs and graduate students, collaborates with clinicians on translational immunology, builds multi-institutional research networks. Professional relationships critical for collaborative grants and multi-site studies, though trust is not the sole value delivered. |
| Goal-Setting & Moral Judgment | 3 | Defines research questions about immune mechanisms, autoimmune pathology, and vaccine targets that nobody has investigated before. Designs novel experimental approaches for studying immune responses in unprecedented contexts. Makes ethical decisions about animal models, human subject research (IRB compliance), and responsible disclosure of findings with public health implications. Frontier immunology -- understanding immune evasion, designing next-generation immunotherapies -- requires genuine novelty with no pre-existing playbook. |
| Protective Total | 5/9 | |
| AI Growth Correlation | 0 | AI adoption neither creates nor destroys immunologist demand. Demand is driven by disease burden (autoimmune diseases, cancer, infectious disease), pharmaceutical R&D investment in immunotherapy ($112B immunology market in 2025, projected $228B by 2034), and fundamental scientific questions. AI makes immunologists more productive but does not change whether humans are needed to conduct the science. |
Quick screen result: Protective 5/9 with strong goal-setting component. Likely Green Zone -- proceed to confirm with task analysis.
Task Decomposition (Agentic AI Scoring)
| Task | Time % | Score (1-5) | Weighted | Aug/Disp | Rationale |
|---|---|---|---|---|---|
| Hypothesis generation & experimental design | 20% | 1 | 0.20 | NOT INVOLVED | Defining what questions to ask about immune system function, autoimmune mechanisms, or vaccine targets requires genuine novelty -- no precedent exists for frontier immunology questions. AI cannot formulate the scientific vision or choose which unexplored immune pathways to investigate. |
| Laboratory experiments (flow cytometry, ELISA, cell culture, animal models) | 25% | 2 | 0.50 | AUGMENTATION | Physical wet lab work in BSL-2/3 environments. AI-powered tools like BD Research Cloud automate panel design, but the immunologist still performs complex assays, troubleshoots protocols, manages animal colonies, and interprets unexpected biological responses. AI assists with experimental optimization but does not execute the work. |
| Data analysis & computational immunology | 15% | 3 | 0.45 | AUGMENTATION | AI/ML tools (e.g., Stanford Mal-ID, single-cell analysis pipelines) handle significant data processing sub-workflows, but immunologists lead interpretation, validate biological plausibility, and connect computational findings to experimental next steps. Human judgment determines which patterns are biologically meaningful versus artefactual. |
| Literature review & synthesis | 10% | 4 | 0.40 | DISPLACEMENT | AI agents can search, summarize, and synthesize immunology literature at scale. Tools already draft literature reviews and identify relevant publications across thousands of journals. Human reviews the output but AI performs the bulk of the retrieval and summarization work. |
| Grant writing & securing funding | 10% | 2 | 0.20 | AUGMENTATION | AI assists with drafting sections and formatting, but the scientific narrative, strategic framing, preliminary data interpretation, and institutional relationships that win grants require human judgment and professional reputation. NIH study sections evaluate scientific vision, not text quality. |
| Manuscript writing & peer review | 10% | 3 | 0.30 | AUGMENTATION | AI drafts sections and assists with figure generation, statistical reporting, and reference management. The immunologist leads the narrative, ensures scientific accuracy, responds to reviewer critiques with experimental judgment, and takes responsibility for the published findings. |
| Mentoring, supervision & collaboration | 5% | 1 | 0.05 | NOT INVOLVED | Training graduate students and postdocs, managing lab dynamics, building collaborative relationships with clinicians and industry partners. Human connection IS the value -- developing the next generation of immunologists cannot be automated. |
| Conference presentations & scientific communication | 5% | 2 | 0.10 | AUGMENTATION | AI assists with slide preparation and data visualization. The immunologist presents, fields questions, defends methodology, and builds the professional relationships that drive collaborative science. |
| Total | 100% | 2.20 |
Task Resistance Score: 6.00 - 2.20 = 3.80/5.0
Displacement/Augmentation split: 10% displacement, 80% augmentation, 10% not involved.
Reinstatement check (Acemoglu): AI creates new tasks for immunologists including computational immunology, AI-guided experimental design, immune repertoire analysis using ML frameworks, and validating AI-generated predictions against biological reality. The role is expanding into computational territory, not shrinking.
Evidence Score
| Dimension | Score (-2 to 2) | Evidence |
|---|---|---|
| Job Posting Trends | +1 | BLS projects 9% growth for biomedical scientists through 2025-2026. Life sciences job market recovery projected at 32% growth in second half of 2025 (GMDP Academy). Immunology-specific postings stable to growing, driven by pharma immunotherapy pipelines and vaccine development. |
| Company Actions | +1 | Major pharma companies (Sanofi, Pfizer, AstraZeneca, Genentech) actively investing in immunology R&D. BD launching AI-powered immunology research tools (Research Cloud 7.0, Jan 2026). No companies cutting immunology researchers citing AI -- investment flowing into the field. Global immunology market valued at $112B in 2025, projected $228B by 2034 (Fortune Business Insights). |
| Wage Trends | 0 | Research immunologist average salary ~$85K-$125K for mid-level research roles, $216K-$295K for clinical immunologists (Glassdoor, Salary.com 2026). Wages stable and competitive but not surging above inflation. Academic salaries constrained by NIH pay scales. |
| AI Tool Maturity | +1 | AI tools augment but do not replace. BD Research Cloud AI-powered panel design, Stanford Mal-ID for immune signature analysis, AlphaFold for protein structure prediction, single-cell analysis pipelines. All positioned as researcher productivity tools, not researcher replacements. Tools create new work (computational immunology, AI validation) within the role. |
| Expert Consensus | +1 | Germain et al. (Immunity, 2024): AI advances immunology research but complements rather than replaces immunologists. Goktas et al. (2025, cited 32 times): AI integration in allergy/immunology improves patient outcomes without displacing researchers. Broad agreement that immunology requires biological intuition and experimental judgment AI cannot provide. |
| Total | 4 |
Barrier Assessment
Reframed question: What prevents AI execution even when programmatically possible?
| Barrier | Score (0-2) | Rationale |
|---|---|---|
| Regulatory/Licensing | 1 | IRB approval required for human subjects research. IACUC oversight for animal models. BSL-2/3 facility certifications. No professional license required for research immunologists specifically, but institutional compliance frameworks create moderate regulatory friction. |
| Physical Presence | 1 | Wet lab work requires physical presence -- handling biological materials, operating flow cytometers and other instruments, managing animal colonies. Structured laboratory environment, not unstructured, but cannot be done remotely by AI. |
| Union/Collective Bargaining | 0 | No significant union representation for research immunologists in academic or industry settings. At-will employment typical. |
| Liability/Accountability | 1 | Research integrity -- falsified data, plagiarism, IRB violations carry serious professional consequences including career destruction, institutional sanctions, and potential legal liability. Principal investigators bear personal accountability for published findings and grant expenditures. |
| Cultural/Ethical | 1 | Society expects human scientists to make ethical judgments about research direction, particularly in sensitive areas like gain-of-function research, human tissue experimentation, and vaccine development. Cultural trust in human scientific judgment persists, especially post-pandemic. |
| Total | 4/10 |
AI Growth Correlation Check
Confirmed 0. AI adoption does not directly increase or decrease demand for immunologists. The immunology market is growing rapidly ($112B to $228B by 2034, 12.1% CAGR) but this growth is driven by disease burden, ageing populations, cancer immunotherapy demand, and autoimmune disease prevalence -- not by AI adoption itself. AI makes immunologists more productive and creates new computational subspecialties, but the fundamental need for human researchers to generate hypotheses, run experiments, and interpret biological systems is independent of AI growth. This is Green (Transforming), not Green (Accelerated).
JobZone Composite Score (AIJRI)
| Input | Value |
|---|---|
| Task Resistance Score | 3.80/5.0 |
| Evidence Modifier | 1.0 + (4 x 0.04) = 1.16 |
| Barrier Modifier | 1.0 + (4 x 0.02) = 1.08 |
| Growth Modifier | 1.0 + (0 x 0.05) = 1.00 |
Raw: 3.80 x 1.16 x 1.08 x 1.00 = 4.76
JobZone Score: (4.76 - 0.54) / 7.93 x 100 = 53.2/100
Zone: GREEN (Green >= 48)
Sub-Label Determination
| Metric | Value |
|---|---|
| % of task time scoring 3+ | 35% (data analysis 15% + literature review 10% + manuscript writing 10%) |
| AI Growth Correlation | 0 |
| Sub-label | GREEN (Transforming) -- AIJRI >= 48 AND >= 20% of task time scores 3+ |
Assessor override: None -- formula score accepted. Score of 53.2 is consistent with calibration anchors: Medical Scientist (54.5), Biochemist (53.2), and Microbiologist (49.8). The immunologist sits squarely in the same band as comparable mid-level life science research roles.
Assessor Commentary
Score vs Reality Check
The Green (Transforming) label is honest and well-calibrated. The score of 53.2 places immunologists in the same zone as medical scientists (54.5), biochemists (53.2), and microbiologists (49.8) -- which reflects reality. These are all hypothesis-driven research roles with significant wet lab components and similar AI exposure profiles. The score is not borderline (5+ points above the Green threshold of 48). No override is needed.
What the Numbers Don't Capture
- Market growth vs headcount growth. The immunology therapeutics market is growing explosively (12% CAGR), but this does not guarantee proportional headcount growth. Pharma companies may invest more per researcher using AI-augmented workflows rather than hiring proportionally more immunologists. The evidence score reflects current hiring reality, not market size.
- Bimodal distribution within "immunologist." The title spans computational immunologists (who may face more AI competition in data analysis tasks) and experimental immunologists (who are more physically protected). The assessment scores the typical mid-level researcher doing both -- those skewed entirely toward computational work may face more Yellow-zone pressure.
- Academic funding constraints. NIH funding levels and academic tenure-track availability constrain headcount growth independently of AI. Positive market evidence partly reflects industry demand while academic positions remain competitive.
- Rate of AI capability improvement. AI tools for immunology data analysis (single-cell genomics, immune repertoire modelling) are advancing rapidly. The augmentation classification for data analysis could shift toward displacement within 5-7 years if AI achieves reliable biological interpretation without human validation.
Who Should Worry (and Who Shouldn't)
If you are a mid-level immunologist who designs experiments, runs complex wet lab protocols, and interprets biological results -- you are well-protected. The core of your work requires genuine scientific novelty and physical laboratory presence that AI cannot replicate. If you are an immunologist whose work has drifted entirely into computational analysis and bioinformatics with no wet lab component, your risk profile is closer to a data scientist and the Green label may overstate your safety. The single biggest factor separating the safe version from the at-risk version is whether you generate original hypotheses and run physical experiments, or whether you primarily analyse datasets that AI agents can increasingly process independently.
What This Means
The role in 2028: The surviving immunologist will be an "AI-augmented researcher" -- using ML tools for immune repertoire analysis, AI-powered experimental design optimization, and automated literature synthesis, while focusing human effort on hypothesis generation, complex wet lab work, biological interpretation, and cross-disciplinary collaboration. Computational immunology skills will be expected alongside traditional bench expertise.
Survival strategy:
- Build computational immunology skills -- learn to use ML frameworks for single-cell analysis, immune receptor prediction, and AI-guided experimental design alongside traditional bench work
- Maintain strong wet lab expertise as a differentiator -- the physical, hands-on component of immunology research is your most durable competitive advantage against AI
- Develop translational partnerships with clinicians and industry -- immunologists who bridge basic research and clinical application are harder to automate and more valuable to institutions
Timeline: 10+ years. The immunology research role is transforming in workflow but not in fundamental demand. AI accelerates the science; it does not replace the scientist.
